J2403 – Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ2403
- Long description
- Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
- Short description
- Chloroprocaine opht gel, 1mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- April 1, 2023
- Last change
- April 1, 2023 – No change
Frequently asked questions
What is HCPCS code J2403?
J2403 is a HCPCS Level II code for chloroprocaine hcl ophthalmic, 3% gel, 1 mg.
Does Medicare cover J2403?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J2370 – Injection, phenylephrine hcl, up to 1 ml
- J2371 – Injection, phenylephrine hydrochloride, 20 micrograms
- J2372 – Injection, phenylephrine hydrochloride (biorphen), 20 micrograms
- J2373 – Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms
- J2374 – Apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml
- J2400 – Injection, chloroprocaine hydrochloride, per 30 ml
- J2401 – Injection, chloroprocaine hydrochloride, per 1 mg
- J2402 – Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
- J2404 – Injection, nicardipine, 0.1 mg
- J2405 – Injection, ondansetron hydrochloride, per 1 mg
- J2406 – Injection, oritavancin (kimyrsa), 10 mg
- J2407 – Injection, oritavancin (orbactiv), 10 mg
- J2410 – Injection, oxymorphone hcl, up to 1 mg
- J2425 – Injection, palifermin, 50 micrograms
- J2426 – Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
- J2427 – Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.